Management of chronic ocular sarcoidosis: challenges and solutions

References

• YoungRCJrRachalRECowanCLJrSarcoidosis – the beginning: historical highlights of personalities and their accomplishments during the early yearsJ Natl Med Assoc1984768878966387158
   PubMed Web of Science ®Google Scholar
• HeerfordtCFOn febris uveo parotidea subchronica localized in the parotid gland and uvea of the eye, frequently complicated by paralysis of the cerebrospinal nervesUgeskr Laeger190971417421
   Google Scholar
• Al-KofahiKKorstenPAscoliCManagement of extrapulmonary sarcoidosis: challenges and solutionsTher Clin Risk Manag2016121623163427853374
   PubMed Web of Science ®Google Scholar
• IannuzziMCRybickiBATeirsteinASSarcoidosisN Engl J Med20073572153216518032765
   PubMed Web of Science ®Google Scholar
• DubreySShahSHardmanTSharmaRSarcoidosis: the links between epidemiology and aetiologyPostgrad Med J20149058258925230946
   PubMed Web of Science ®Google Scholar
• GotoHMochizukiMYamakiKKotakeSUsuiMOhnoSEpidemiological survey of intraocular inflammation in JapanJpn J Ophthalmol2007511414417295139
   PubMed Web of Science ®Google Scholar
• GroenFRothovaAOcular involvement in sarcoidosisSemin Respir Crit Care Med20173851452228750464
   PubMed Web of Science ®Google Scholar
• ChesnuttANEnigmas in sarcoidosisWest J Med19951625195267618312
   PubMedGoogle Scholar
• CostabelUHunninghakeGWATS/ERS/WASOG statement on sarcoidosisEur Respir J19991473573710573213
   PubMed Web of Science ®Google Scholar
• AcharyaNRBrowneENRaoNMochizukiMDistinguishing features of ocular sarcoidosis in an international cohort of uveitis patientsOphthalmology201812511912628823384
   PubMed Web of Science ®Google Scholar
• HerbortCPRaoNAMochizukiMInternational criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS)Ocul Immunol Inflamm20091716016919585358
   PubMed Web of Science ®Google Scholar
• SaketkooLABaughmanRPBiologic therapies in the treatment of sarcoidosisExpert Rev Clin Immunol20161281782527117719
   PubMed Web of Science ®Google Scholar
• KiszałkiewiczJPiotrowskiWJBrzeziańska-LasotaESelected molecular events in the pathogenesis of sarcoidosis: recent advancesPneumonol Alergol Pol20158346247526559800
   PubMedGoogle Scholar
• NewmanLSRoseCSBresnitzEAA case control etiologic study of sarcoidosis: environmental and occupational risk factorsAm J Respir Crit Care Med20041701324133015347561
   PubMed Web of Science ®Google Scholar
• FischerARybickiBAGranuloma genes in sarcoidosis: what is new?Curr Opin Pulm Med20152151051626164297
   PubMed Web of Science ®Google Scholar
• WilliamsGTWilliamsWJGranulomatous inflammation: a reviewJ Clin Pathol1983367237336345591
   PubMed Web of Science ®Google Scholar
• RiveraNVHagemann-JensenMFerreiraMACommon variants of T-cells contribute differently to phenotypic variation in sarcoidosisSci Rep20177562328717140
   PubMed Web of Science ®Google Scholar
• SpagnoloPGrunewaldJRecent advances in the genetics of sarcoidosisJ Med Genet20135029029723526832
   PubMed Web of Science ®Google Scholar
• FingerlinTEHamzehNMaierLAGenetics of sarcoidosisClin Chest Med20153656958426593134
   PubMed Web of Science ®Google Scholar
• BaughmanRPLowerEEKaufmanAHOcular sarcoidosisSemin Respir Crit Care Med20103145246220665395
   PubMed Web of Science ®Google Scholar
• PasadhikaSRosenbaumJTOcular sarcoidosisClin Chest Med201536466968326593141
   PubMed Web of Science ®Google Scholar
• YangSJSalekSRosenbaumJTOcular sarcoidosis: new diagnostic modalities and treatmentCurr Opin Pulm Med20172345846728622198
   PubMed Web of Science ®Google Scholar
• JamillouxYKodjikianLBroussolleCSèvePSarcoidosis and uveitisAutoimmun Rev20141384084924704868
   PubMed Web of Science ®Google Scholar
• RothovaAOcular involvement in sarcoidosisBr J Ophthalmol20008411011610611110
   PubMed Web of Science ®Google Scholar
• El-AsrarAMHerbortCPTabbaraKFDifferential diagnosis of retinal vasculitisMiddle East Afr J Ophthalmol20091620221820404987
   PubMedGoogle Scholar
• KoopAOssewaardeARothovaAPeripheral multifocal chorioretinitis: complications, prognosis and relation with sarcoidosisActa Ophthalmol20139149249722863241
   PubMed Web of Science ®Google Scholar
• DesaiURTawansyKAJoondephBCSchiffmanRMChoroidal granulomas in systemic sarcoidosisRetina200121404711217928
   PubMed Web of Science ®Google Scholar
• CrickRPOcular sarcoidosisTrans Ophthalmol Soc U K19557518920613360914
   PubMedGoogle Scholar
• UyamaMUveitis in sarcoidosisInt Ophthalmol Clin20024214315012189610
   PubMedGoogle Scholar
• DelaneyPNeurologic manifestations in sarcoidosis: review of the literature, with a report of 23 casesAnn Intern Med197787336345197863
   PubMed Web of Science ®Google Scholar
• PhillipsYLEggenbergerERNeuro-ophthalmic sarcoidosisCurr Opin Ophthalmol20102142342920736834
   PubMed Web of Science ®Google Scholar
• KefellaHLutherDHainlineCOphthalmic and neuro-ophthalmic manifestations of sarcoidosisCurr Opin Ophthalmol20172858759428759560
   PubMed Web of Science ®Google Scholar
• UmurKATayfunBOguzhanODifferent ophthalmologic manifestations of sarcoidosisCurr Opin Ophthalmol20122347748423014267
   PubMed Web of Science ®Google Scholar
• BirnbaumADOhFSChakrabartiATesslerHHGoldsteinDAClinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosisArch Ophthalmol201112940941321482866
   PubMedGoogle Scholar
• HeiligenhausAWefelmeyerDWefelmeyerERöselMSchrenkMThe eye as a common site for the early clinical manifestation of sarcoidosisOphthalmic Res20114691221099232
   PubMed Web of Science ®Google Scholar
• Tempest-RoeSJoshiLDickADTaylorSRLocal therapies for inflammatory eye disease in translation: past, present and futureBMC Ophthalmol2013133923914773
   PubMed Web of Science ®Google Scholar
• SheppardJDToyosMMKempenJHKaurPFosterCSDifluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized studyInvest Ophthalmol Vis Sci2014552993300224677110
   PubMed Web of Science ®Google Scholar
• BiswasJGaneshbabuTMRaghavendranSRRaizadaSMondkarSVMadhavanHNEfficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis: a randomized triple masked studyInt Ophthalmol20042514715315847313
   PubMedGoogle Scholar
• FosterCSAlterGDeBargeLREfficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitisAm J Ophthalmol19961221711828694085
   PubMed Web of Science ®Google Scholar
• AgrawalRVMurthySSangwanVBiswasJCurrent approach in diagnosis and management of anterior uveitisIndian J Ophthalmol201058111920029142
   PubMed Web of Science ®Google Scholar
• PavesioCEDecoryHHTreatment of ocular inflammatory conditions with loteprednol etabonateBr J Ophthalmol20089245545918245274
   PubMed Web of Science ®Google Scholar
• No authors listedControlled evaluation of loteprendnol etabonate and prednisolone acetate in the treatment of acute anterior uveitisAm J Ophthalmol199912753754410334346
   PubMed Web of Science ®Google Scholar
• SenHNVitaleSGangaputraSSPeriocular corticosteroid injections in uveitis: effects and complicationsOphthalmology20141212275228625017415
   PubMed Web of Science ®Google Scholar
• SalekSSLederHAButlerNJGanTJDunnJPThorneJEPeriocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitisOcul Immunol Inflamm20132125726323617776
   PubMed Web of Science ®Google Scholar
• ShinJYYuHGIntravitreal triamcinolone injection for uveitic macular edema: a randomized clinical studyOcul Immunol Inflamm20152343043626308286
   PubMed Web of Science ®Google Scholar
• SoheilianMEskandariARamezaniARabbanikhahZSoheilianRA pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edemaOcul Immunol Inflamm20132112412923697857
   PubMed Web of Science ®Google Scholar
• SteeplesLRAnandNMorajiJJonesNPClinical outcomes of intravitreal preservative-free triamcinolone preparation (Triesence) for cystoid macular oedema and inflammation in patients with uveitisOcul Immunol Inflamm20172018
   Google Scholar
• SabzevariAAdibkiaKHashemiHPolymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studiesEur J Pharm Biopharm201384637123295645
   PubMed Web of Science ®Google Scholar
• LowderCBelfortRJrLightmanSDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol201112954555321220619
   PubMed Web of Science ®Google Scholar
• Zarranz-VenturaJCarreñoEJohnstonRLMulticenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequencyAm J Ophthalmol20141581136.e51145.e525217856
   PubMed Web of Science ®Google Scholar
• KhuranaRNPorcoTCEfficacy and safety of dexamethasone intravitreal implant for persistent uveitic cystoids macular edemaRetina2015351640164625741813
   PubMed Web of Science ®Google Scholar
• MiserocchiEModoratiGPastoreMRBandelloFDexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitisOphthalmologica201222822923323038070
   PubMed Web of Science ®Google Scholar
• RyderSJIannettaDBhaleeyaSDKissSEfficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusionClin Ophthalmol201591109111626150689
   PubMed Web of Science ®Google Scholar
• PleyerUKlamannMLaurentTJFast and successful management of intraocular inflammation with a single intravitreal dexamethasone implantOphthalmologica Epub20141121
   Web of Science ®Google Scholar
• CaoJHMulvahillMZhangLJoondephBCDaceyMSDexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammationOphthalmology20141211871187624907061
   PubMed Web of Science ®Google Scholar
• AdánAPelegrínLReyADexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patientsRetina2013331435144023514796
   PubMed Web of Science ®Google Scholar
• TanHYAgarwalALeeCSManagement of noninfectious posterior uveitis with intravitreal drug therapyClin Ophthalmol2016101983202027789936
   PubMedGoogle Scholar
• KempenJHAltaweelMMHolbrookJTRandomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trialOphthalmology20111181916192621840602
   PubMed Web of Science ®Google Scholar
• KempenJHAltaweelMMHolbrookJTSugarEAThorneJEJabsDAAssociation between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitisJAMA20173171993200528477440
   PubMed Web of Science ®Google Scholar
• JaffeGJLinPKeenanRTAshtonPSkalakCStinnettSSInjectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: two-year resultsOphthalmology20161231940194827421623
   PubMed Web of Science ®Google Scholar
• No authors listedQuality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment trial and follow-up studyOphthalmology20151221976198626298718
   PubMed Web of Science ®Google Scholar
• KempenJHAltaweelMMDryeLTBenefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, and panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment (MUST) trial and follow-up studyOphthalmology20151221967197526298715
   PubMed Web of Science ®Google Scholar
• SugarEAVenugopalVThorneJELongitudinal vision-related quality of life for patients with noninfectious uveitis treated with fluocinolone acetonide implant or systemic corticosteroid therapyOphthalmology20171241662166928624167
   PubMed Web of Science ®Google Scholar
• CabreraMYehSAlbiniTASustained-release corticosteroid optionsJ Ophthalmol2014201416469225140246
   PubMed Web of Science ®Google Scholar
• BrowneENRathinamSRKanakathAA Bayesian analysis of a randomized clinical trial comparing antimetabolite therapies for non-infectious uveitisOphthalmic Epidemiol2017241637027982726
   PubMed Web of Science ®Google Scholar
• RathinamSRBabuMThundikandyRA randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitisOphthalmology20141211863187024917273
   PubMed Web of Science ®Google Scholar
• BaughmanRPLowerEEIngledueRKaufmanAHManagement of ocular sarcoidosisSarcoidosis Vasc Diffuse Lung Dis201229263323311120
   PubMed Web of Science ®Google Scholar
• BitounSBouvryDBorieRTreatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetilNeurology2016872517252127856779
   PubMed Web of Science ®Google Scholar
• KaçmazROKempenJHNewcombCCyclosporine for ocular inflammatory diseasesOphthalmology201011757658420031223
   PubMed Web of Science ®Google Scholar
• PasadhikaSKempenJHNewcombCWAzathioprine for ocular inflammatory diseasesAm J Ophthalmol2009148500.e2509.e219570522
   PubMed Web of Science ®Google Scholar
• TaylorSRBankerASchlaenAIntraocular methotrexate can induce extended remission in some patients in noninfectious uveitisRetina2013332149215423615343
   PubMed Web of Science ®Google Scholar
• AirodyAHeathGLightmanSGaleRNon-infectious uveitis: optimising the therapeutic responseDrugs201676273926645222
   PubMed Web of Science ®Google Scholar
• ZiegenhagenMWRotheMEZisselGExaggerated TNFα release of alveolar macrophages in corticosteroid resistant sarcoidosisSarcoidosis Vasc Diffuse Lung Dis20021918519012405487
   PubMed Web of Science ®Google Scholar
• LimLLFraunfelderFWRosenbaumJTDo tumor necrosis factor inhibitors cause uveitis? A registry-based studyArthritis Rheum2007563248325217907169
   PubMed Web of Science ®Google Scholar
• JaffeGJDickADBrezinAPAdalimumab in patients with active noninfectious uveitisN Engl J Med201637593294327602665
   PubMed Web of Science ®Google Scholar
• NguyenQDMerrillPTJaffeGJAdalimumab for prevention of uveitic flare in patients with inactive noninfectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trialLancet20163881183119227542302
   PubMed Web of Science ®Google Scholar
• SuhlerEBLowderCYGoldsteinDAAdalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trialBr J Ophthalmol20139748148623376607
   PubMed Web of Science ®Google Scholar
• Riancho-ZarrabeitiaLCalvo-RíoVBlancoRAnti-TNF-α therapy in refractory uveitis associated with sarcoidosis: multicenter study of 17 patientsSemin Arthritis Rheum20154536136826092330
   PubMed Web of Science ®Google Scholar
• MercierAERibeiroEKorobelnikJFDelyferMNRougierMBEfficacy of anti-TNF-α therapy for the treatment of non-infectious uveitis: a retrospective study of 21 patientsOcul Immunol Inflamm Epub20161024
   Web of Science ®Google Scholar
• ErckensRJMostardRLWijnenPASchoutenJSDrentMAdalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitisGraefes Arch Clin Exp Ophthalmol201225071372022119879
   PubMed Web of Science ®Google Scholar
• AgrawalRIyerJConnollyJIwataDTeohSCytokines and biologics in non-infectious autoimmune uveitis: bench to bedsideIndian J Ophthalmol201462748124492505
   PubMed Web of Science ®Google Scholar
• ValletHSevePBiardLInfliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis NetworkArthritis Rheumatol20166861522153027015607
   PubMed Web of Science ®Google Scholar
• KruhJNYangPSuelvesAMFosterCSInfliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-upOphthalmology201412135836424011995
   PubMed Web of Science ®Google Scholar
• Brito-ZerónPPerez-AlvarezRRamos-CasalsMEtanercept and uveitis: friends or foes?Curr Med Res Opin20153125125225438042
   PubMed Web of Science ®Google Scholar
• DaïenCIMonnierAClaudepierrePSarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesRheumatology (Oxford)20094888388619423648
   PubMed Web of Science ®Google Scholar
• HashkesPJShajrawiISarcoid-related uveitis occurring during etanercept therapyClin Exp Rheumatol20032164564614611117
   PubMed Web of Science ®Google Scholar
• SmithJAThompsonDJWhitcupSMA randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritisArthritis Rheum200553182315696578
   PubMed Web of Science ®Google Scholar
• Cordero-ComaMCalvo-RíoVAdánAGolimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experienceMediators Inflamm2014201471759824976689
   PubMed Web of Science ®Google Scholar
• PasadhikaSRosenbaumJTUpdate on the use of systemic biologic agents in the treatment of noninfectious uveitisBiologics2014156781
   Google Scholar
• Cordero-ComaMYilmazTOnalSSystematic review of anti-tumor necrosis factor-α therapy for treatment of immune-mediated uveitisOcul Immunol Inflamm201321192723323577
   PubMed Web of Science ®Google Scholar
• Borrás-BlascoJCasteráDECortesXAbadFJRosique-RoblesJDMallenchLGEffectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adultsInt J Clin Pharmacol Ther20155337739025345430
   PubMed Web of Science ®Google Scholar
• LlorençVMesquidaMde la MazaMSCertolizumab pegol, a new anti-TNF-α in the armamentarium against ocular inflammationOcul Immunol Inflamm20162416717225325834
   PubMed Web of Science ®Google Scholar
• WroblewskiKSenHNYehSLong-term daclizumab therapy for the treatment of noninfectious ocular inflammatory diseaseCan J Ophthalmol20114632232821816251
   PubMed Web of Science ®Google Scholar
• LowerEEBaughmanRPKaufmanAHRituximab for refractory granulomatous eye diseaseClin Ophthalmol201261613161823055686
   PubMedGoogle Scholar
• SweissNJLowerEEMirsaeidiMRituximab in the treatment of refractory pulmonary sarcoidosisEur Respir J2014431525152824488568
   PubMed Web of Science ®Google Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol200013049251311024423
   PubMed Web of Science ®Google Scholar